[1
]From the Department of Cardiology (A.C., H.E., C.T., F.B., G.D., F.A.), Charles Nicolle
Hospital, University of Rouen, Rouen, France; the Centre d’Experimentation et de Recherche
Appliquée (CERA) (N.B., F.L.), Institut Montsouris, Paris, France; the Cardiovascular
Research Foundation (M.B.L.), Lenox Hill Hospital, New York, NY; and Percutaneous
Valve Technologies, Fort Lee, NJ (A.B.).